SCA
ELAN icon

Stuart Chaussee & Associates’s Elanco Animal Health ELAN Stock Holding History

Stuart Chaussee & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-180
Closed -$5K – 177
2021
Q1 		$5K Buy
+180
New +$5.54K ﹤0.01% 171

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Stuart Chaussee & Associates's ELAN Position: Q2 2021 in Review

Stuart Chaussee & Associates sold out of Elanco Animal Health (ELAN) in Q2 2021, closing a stake of 180 shares — an estimated $5K sold.

Stuart Chaussee & Associates first reported a position in ELAN in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 479 funds tracked by Wall St. Rank hold ELAN as of Q2 2021.

  • Stuart Chaussee & Associates reported no remaining Elanco Animal Health position as of Q2 2021 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 180 Elanco Animal Health shares in Q2 2021, an estimated $5K.
  • Stuart Chaussee & Associates first reported a position in Elanco Animal Health in Q1 2021 and held it in 1 quarter.
  • Stuart Chaussee & Associates's Elanco Animal Health position peaked at $5K in Q1 2021.
  • 479 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2021.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.